Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Androgens affect skin conditions like acne and hirsutism, treatable with hormone therapy and other methods.

A 13-year-old girl's masculine symptoms improved after surgery for a rare adrenal tumor that produced male hormones.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Androgenetic alopecia is more common in men, often linked to genetics and hormones.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Testosterone's effects on COVID-19 are unclear and need more research.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Delayed puberty often runs in families, can affect growth, and may need hormone treatment.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Testosterone, DHT, and estradiol significantly affect hair cell growth.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

A woman's rare ovarian tumor was treated with surgery, which stopped her symptoms and normalized her hormone levels.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Testosterone helps prevent skin damage in males by acting through both estrogen and androgen pathways.